ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 890 filers reported holding ISHARES TR in Q4 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $566,814 | -6.7% | 4,635 | -3.1% | 0.08% | -8.8% |
| Q2 2023 | $607,504 | -1.7% | 4,785 | 0.0% | 0.09% | -8.1% |
| Q1 2023 | $618,031 | -7.4% | 4,785 | -5.9% | 0.10% | -14.7% |
| Q4 2022 | $667,610 | +12.2% | 5,085 | 0.0% | 0.12% | +8.4% |
| Q3 2022 | $595,000 | -0.5% | 5,085 | 0.0% | 0.11% | +3.9% |
| Q2 2022 | $598,000 | -14.8% | 5,085 | -5.6% | 0.10% | 0.0% |
| Q1 2022 | $702,000 | -14.6% | 5,385 | 0.0% | 0.10% | -11.2% |
| Q4 2021 | $822,000 | -5.6% | 5,385 | 0.0% | 0.12% | -7.2% |
| Q3 2021 | $871,000 | -1.1% | 5,385 | 0.0% | 0.12% | -4.6% |
| Q2 2021 | $881,000 | -3.3% | 5,385 | -11.0% | 0.13% | -7.1% |
| Q1 2021 | $911,000 | +114.4% | 6,051 | +115.7% | 0.14% | +85.5% |
| Q4 2020 | $425,000 | -40.8% | 2,805 | -47.1% | 0.08% | -42.4% |
| Q3 2020 | $718,000 | -23.0% | 5,305 | -22.2% | 0.13% | -30.9% |
| Q2 2020 | $932,000 | +50.1% | 6,815 | +18.2% | 0.19% | +27.3% |
| Q1 2020 | $621,000 | -26.0% | 5,765 | -17.2% | 0.15% | -6.8% |
| Q4 2019 | $839,000 | +40.3% | 6,965 | +15.8% | 0.16% | +21.1% |
| Q3 2019 | $598,000 | -8.4% | 6,015 | +0.5% | 0.13% | -35.1% |
| Q2 2019 | $653,000 | -1.7% | 5,985 | +0.8% | 0.20% | +16.5% |
| Q1 2019 | $664,000 | +15.1% | 5,935 | -0.8% | 0.18% | -13.3% |
| Q4 2018 | $577,000 | -19.7% | 5,980 | +1.4% | 0.20% | +29.3% |
| Q3 2018 | $719,000 | +7.3% | 5,895 | -3.4% | 0.16% | +4.0% |
| Q2 2018 | $670,000 | +76.8% | 6,105 | +71.7% | 0.15% | +64.1% |
| Q1 2018 | $379,000 | -13.3% | 3,555 | -13.2% | 0.09% | -14.8% |
| Q4 2017 | $437,000 | -3.7% | 4,095 | +201.1% | 0.11% | -4.4% |
| Q3 2017 | $454,000 | +28.6% | 1,360 | +19.3% | 0.11% | +20.2% |
| Q2 2017 | $353,000 | +8.3% | 1,140 | +2.7% | 0.09% | +5.6% |
| Q1 2017 | $326,000 | +35.3% | 1,110 | +22.0% | 0.09% | +23.6% |
| Q4 2016 | $241,000 | +127.4% | 910 | +149.3% | 0.07% | +125.0% |
| Q3 2016 | $106,000 | -28.9% | 365 | -37.1% | 0.03% | -33.3% |
| Q2 2016 | $149,000 | +198.0% | 580 | +176.2% | 0.05% | +152.6% |
| Q1 2014 | $50,000 | +354.5% | 210 | +320.0% | 0.02% | +375.0% |
| Q4 2013 | $11,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |